Dentists in Ely, MN Accepting Medicare
6 Dentists found. Showing 1 - 6
 Dr. Crystal Chopp, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 33 E Chapman St, Ely, MN 55731 Phone: 218-365-3194 |
 Spencer Wihlm, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 40 N 1st Ave E Ste 5, Ely, MN 55731 Phone: 218-365-3565 |
Scott Robert Anderson, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 33 E Chapman St, Ely, MN 55731 Phone: 218-365-3194 |
Dr. Jacob Isaac Ihle, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 40 N 1st Ave E, Suite #5, Ely, MN 55731 Phone: 218-365-3145 |
Mr. William James Scott, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 40 N 1st Ave E, Ely, MN 55731 Phone: 218-365-3145 |
Dr. Frank Theodore Udovich, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 21 E Chapman St, Ely, MN 55731 Phone: 218-365-3259 |
News Archive
FDA approves new breakthrough Parkinson's drug
FDA has approved Apokyn (apomorphine) as an injectable drug for treating Parkinson's patients during episodes of "hypomobility," so-called "off periods" in which the patient becomes immobile or unable to perform activities of daily living.
Researchers find that pregnant women in Brooklyn have highest level of methyl paraben, propyl paraben
Researchers at SUNY Downstate Medical Center and Arizona State University have published the first study of levels of parabens - antibacterial substances commonly used as preservatives in cosmetics and other products - in human cord blood samples. The researchers found that a cohort of pregnant women in Brooklyn predominantly of Caribbean- and African-American descent had the highest level worldwide of methyl paraben and propyl paraben.
Erectile dysfunction can affect a man's quality of life, but treatable
By age 50, nearly half of men experience some degree of erectile dysfunction. Advertisements for medications treating the condition have been all over mainstream media for years.
NIH awards 12 research grants totaling $5 million for Tβ4 research
REGENERX BIOPHARMACEUTICALS, INC. announced today that National Institutes of Health (NIH) has awarded 12 research grants totaling over $5,000,000 for the study of Tβ4 in 2009/2010. Many of these grants will be going to collaborators with whom RegeneRx is working to understand its numerous biological activities and capabilities in medical indications, including the role of Tβ4 as an anti-inflammatory agent in tissue regeneration and its promotion of stem cell maturation.
High-risk, high-cost PCI patients can be identified through pre-procedure bleeding risk score
A pre-procedure bleeding risk score can accurately identify high-risk, high-cost patients and may provide an opportunity to employ bleeding avoidance strategies to improve patient outcomes and reduce total costs related to percutaneous coronary intervention (PCI) procedures, according to a retrospective study being presented March 26 at the 61st annual American College of Cardiology (ACC) scientific session.
› Verified 4 days ago